Business UpdateAug 5, 2026, 04:06 PM

Sight Sciences' OMNI & SION Receive Aetna Coverage

AI Summary

Sight Sciences announced that Aetna, Inc.'s updated Glaucoma Surgery Policy now recognizes its OMNI Surgical System and SION Surgical Instrument as medically necessary. This policy change establishes coverage for these interventional glaucoma technologies for the treatment of mild-to-moderate open-angle glaucoma, effective July 14, 2026. The company stated this milestone provides broad payer access across all major national payers for its implant-free MIGS procedures, impacting Aetna's approximately 25 million commercial covered lives.

Key Highlights

Aetna's updated Glaucoma Surgery Policy now covers OMNI and SION.
OMNI and SION are recognized as medically necessary for mild-to-moderate open-angle glaucoma.
The coverage is for implant-free, minimally invasive glaucoma surgery (MIGS) procedures.
The policy is retroactive to July 14, 2026.
Aetna covers approximately 25 million commercial lives.
This establishes broad payer access for the company's technologies.

View SEC Filing

SGHT

Medical/Dental Instruments

Sight Sciences, Inc.

Price Impact